ArticleCureus2025
Bilateral Facial Nerve Palsy Revealing Diffuse Large B-Cell Lymphoma With Leptomeningeal Involvement.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We present a diagnostically challenging case of a 54-year-old woman who developed progressive bilateral lower motor neuron (LMN) facial nerve palsy, later accompanied by lower limb weakness and impaired dexterity. The initial presentation was misattributed to idiopathic Bell's palsy, which delayed recognition of a more serious underlying condition. Neuroimaging revealed enhancement of multiple cranial nerves and diffuse leptomeningeal involvement. Cerebrospinal fluid (CSF) analysis demonstrated lymphocytic pleocytosis, elevated protein levels, low glucose, and increased lactate dehydrogenase (LDH), findings suggestive of a malignant infiltrative process. Additional imaging of the spine and plexus showed diffuse marrow signal abnormalities, cauda equina enhancement, and a right C5 nerve root mass with bony erosion. A diagnosis of stage IVA diffuse large B-cell lymphoma (DLBCL) with central nervous system (CNS) and leptomeningeal involvement was established during admission. The patient was referred to hematology, and a multidisciplinary team recommended systemic chemotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix) or rituximab, ifosfamide, carboplatin, and etoposide (RICE), followed by autologous stem cell transplantation for consolidation. This case highlights a rare presentation of CNS lymphoma and underscores the importance of early consideration of malignancy in patients presenting with progressive cranial neuropathies and polyradiculopathy, particularly in the absence of constitutional or systemic symptoms. Timely neuroimaging and CSF analysis were instrumental in achieving an accurate diagnosis, allowing for early initiation of appropriate therapy in this aggressive disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.